-
Study transmission risk and viral load in plasma and genital secretions.
-
Correlate cell-free and cell-associated viral load in genital secretions to risk of transmission.
-
Investigate effect of vaccines on peak viral loads.
-
Define the impact of co-pathogens (especially STDs) and hormones on vaccine and/or microbicide effectiveness in efficacy trials.
-
Weigh the contribution of HIV–DC interaction to transmission in animal experiments.
-
Isolate HIV from genital secretions.
-
Identify mechanisms that restrict HIV replication in genital tract explants, including innate immunity.
-
Evaluate mucosal boosting after systemic priming in order to induce genital immune responses.
-
Evaluate inclusion of HIV-1 antigens, especially Env protein, as immunogens in microbicides.
-
Improve mucosal immunogenicity—e.g., by incorporating Toll-like receptor ligands in vaccines/microbicides.